119 related articles for article (PubMed ID: 29424203)
1. Clinicopathological significance of chemokine receptor CXCR4 expression in papillary thyroid carcinoma: a meta-analysis.
Wu Z; Cao Y; Jiang X; Li M; Wang G; Yang Y; Lu K
Minerva Endocrinol; 2020 Mar; 45(1):43-48. PubMed ID: 29424203
[TBL] [Abstract][Full Text] [Related]
2. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Luo HJ; Yin GB; Dong CR; Xu M; Chen GG; Liu ZM
Clin Dev Immunol; 2013; 2013():589423. PubMed ID: 24288553
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer.
Ma H; Wang R; Fang J; Zhong Q; Chen X; Hou L; Feng L; Chen X; Huang Z; Zhao H
Medicine (Baltimore); 2020 Jan; 99(5):e18917. PubMed ID: 32000400
[TBL] [Abstract][Full Text] [Related]
5. Expression of CXCR4 and CXCR7 in papillary thyroid carcinoma and adjacent tissues and their relationship with pathologic indicators of tumor aggressiveness.
Cao X; Zhu J; Li X; Ma Y; He Q
Endocr J; 2022 Feb; 69(2):189-197. PubMed ID: 34588386
[TBL] [Abstract][Full Text] [Related]
6. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
Zhang Q; Liu SZ; Zhang Q; Guan YX; Chen QJ; Zhu QY
Cell Physiol Biochem; 2016; 38(2):763-76. PubMed ID: 26871894
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of matrix metalloproteinase-9 expression in papillary thyroid carcinoma: a meta-analysis.
Wen J; Qin X; Zhang J; Wu X; Yan X; Lu K; Yang P; Ji S; Zhao X; Wang Y
World J Surg Oncol; 2023 Jul; 21(1):225. PubMed ID: 37496069
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of epidermal growth factor receptor expression in papillary thyroid carcinoma: a meta-analysis.
Qin XR; Huang JK; Yin QF; Shi XM; Tang JC; Hao LL; Li PF; Zhu J; Wang YX
Minerva Endocrinol; 2021 Jan; ():. PubMed ID: 33435649
[TBL] [Abstract][Full Text] [Related]
10. Association between TSHR gene methylation and papillary thyroid cancer: a meta-analysis.
Qu M; Wan S; Ren B; Wu H; Liu L; Shen H
Endocrine; 2020 Sep; 69(3):508-515. PubMed ID: 32279226
[TBL] [Abstract][Full Text] [Related]
11. Altered chemokine receptor expression in papillary thyroid cancer.
González HE; Leiva A; Tobar H; Böhmwald K; Tapia G; Torres J; Mosso LM; Bueno SM; Gonzalez P; Kalergis AM; Riedel CA
Thyroid; 2009 Sep; 19(9):957-65. PubMed ID: 19731977
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of BRAF
Song JY; Sun SR; Dong F; Huang T; Wu B; Zhou J
Curr Med Sci; 2018 Oct; 38(5):785-797. PubMed ID: 30341513
[TBL] [Abstract][Full Text] [Related]
14. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis.
Wu J; Wu X; Liang W; Chen C; Zheng L; An H
Tumour Biol; 2014 Apr; 35(4):3709-15. PubMed ID: 24326770
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis.
Yasuoka H; Kodama R; Hirokawa M; Takamura Y; Miyauchi A; Sanke T; Nakamura Y
BMC Cancer; 2008 Sep; 8():274. PubMed ID: 18826577
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA-seq reveals MIF-(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.
Chen W; Yu X; Li H; Yuan S; Fu Y; Hu H; Liu F; Zhang Y; Zhong S
Oral Oncol; 2024 Jan; 148():106654. PubMed ID: 38061122
[TBL] [Abstract][Full Text] [Related]
19. RANKL, OPG, TRAIL, KRas, and c-Fos expression in relation to central lymph node metastases in papillary thyroid carcinoma.
Deligiorgi MV; Mahaira H; Eftychiadis C; Kafiri G; Georgiou G; Theodoropoulos G; Konstadoulakis MM; Zografos E; Zografos GC
J BUON; 2018; 23(4):1029-1040. PubMed ID: 30358208
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of loss of p27kip1 expression in papillary thyroid carcinoma.
Kim NY; Kim JH; Pyo JS; Jin Cho W
Int J Biol Markers; 2017 May; 32(2):e255-e259. PubMed ID: 27834461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]